BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sunada F, Itabashi M, Ohkura H, Okumura T. p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy. World J Gastroenterol 2005; 11(36): 5696-5700 [PMID: 16237768 DOI: 10.3748/wjg.v11.i36.5696]
URL: https://www.wjgnet.com/1007-9327/full/v11/i36/5696.htm
Number Citing Articles
1
Kohei Wakatsuki, Sohei Matsumoto, Kazuhiro Migita, Masahiro Ito, Tomohiro Kunishige, Hiroshi Nakade, Mitsuhiro Nakatani, Mutsuko Kitano, Masato Takano, Chiho Obayashi, Masayuki Sho. Usefulness of computed tomography density of a tumor in predicting the response of advanced esophageal cancer to preoperative chemotherapySurgery 2017; 162(4): 823 doi: 10.1016/j.surg.2017.06.003
2
TOSHIHARU MATSUMOTO. Prediction of the effects of chemoradiotherapy based on oncoprotein expression and individualized therapy for squamous cell carcinoma of the esophagusJuntendo Medical Journal 2007; 53(4): 576 doi: 10.14789/pjmj.53.576
3
Rose Boutros, Valérie Lobjois, Bernard Ducommun. CDC25 phosphatases in cancer cells: key players? Good targets?Nature Reviews Cancer 2007; 7(7): 495 doi: 10.1038/nrc2169
4
Seok Yun Kang, Jae Ho Han, Kwang Jae Lee, Jin-Hyuk Choi, Jung Il Park, Hyoung Il Kim, Hyun-Woo Lee, Jun Ho Jang, Joon Seong Park, Hugh Chul Kim, Seunghee Kang, Young Taek Oh, Mison Chun, Jang Hee Kim, Seung Soo Sheen, Ho-Yeong Lim. Low Expression of Bax Predicts Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Treated with Definitive ChemoradiotherapyClinical Cancer Research 2007; 13(14): 4146 doi: 10.1158/1078-0432.CCR-06-3063
5
G Weinlich, G Topar, K Eisendle, PO Fritsch, B Zelger. Comparison of metallothionein‐overexpression with sentinel lymph node biopsy as prognostic factors in melanomaJournal of the European Academy of Dermatology and Venereology 2007; 21(5): 669 doi: 10.1111/j.1468-3083.2006.02051.x
6
Chueh‐Chuan Yen, Yen‐Po Tsao, Paul Chih‐Hsueh Chen, Yu‐Chung Wu, Jin‐Hwang Liu, Chin‐Chen Pan, Chun‐Yu Liu, Cheng‐Hwai Tzeng, Po‐Min Chen, Yann‐Jang Chen, Chi‐Hung Lin, Wen‐Hu Hsu. PML protein as a prognostic molecular marker for patients with esophageal squamous cell carcinomas receiving primary surgeryJournal of Surgical Oncology 2011; 103(8): 761 doi: 10.1002/jso.21855
7
William J. Faller, Mairin Rafferty, Shauna Hegarty, Gabriela Gremel, Denise Ryan, Mario F. Fraga, Manel Esteller, Peter A. Dervan, William M. Gallagher. Metallothionein 1E is methylated in malignant melanoma and increases sensitivity to cisplatin-induced apoptosisMelanoma Research 2010; 20(5): 392 doi: 10.1097/CMR.0b013e32833d32a6
8
G Weinlich, K Eisendle, E Hassler, M Baltaci, P O Fritsch, B Zelger. Metallothionein – overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patientsBritish Journal of Cancer 2006; 94(6): 835 doi: 10.1038/sj.bjc.6603028
9
Montserrat García, Lydia Álvarez, Ángela Fernández, Héctor González-Iglesias, Julio Escribano, Beatriz Fernández-Vega, Eva Villota, Luis Fernández-Vega Cueto, Álvaro Fernández-Vega, Miguel Coca-Prados. Metallothionein polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degenerationOphthalmic Genetics 2017; 38(5): 451 doi: 10.1080/13816810.2017.1288825
10
Yang Li, He-Cheng Huang, Long-Qi Chen, Li-Yan Xu, En-Min Li, Jian-Jun Zhang. Predictive biomarkers for response of esophageal cancer to chemo(radio)therapy: A systematic review and meta-analysisSurgical Oncology 2017; 26(4): 460 doi: 10.1016/j.suronc.2017.09.003
11
G Weinlich, B Zelger. Metallothionein overexpression, a highly significant prognostic factor in thin melanomaHistopathology 2007; 51(2): 280 doi: 10.1111/j.1365-2559.2007.02744.x
12
Jarmila Kruseova, David Hynek, Vojtech Adam, Rene Kizek, Richard Prusa, Jan Hrabeta, Tomas Eckschlager. Serum Metallothioneins in Childhood Tumours — A Potential Prognostic MarkerInternational Journal of Molecular Sciences 2013; 14(6): 12170 doi: 10.3390/ijms140612170
13
Jaromir Gumulec, Martina Raudenska, Vojtech Adam, Rene Kizek, Michal Masarik, Renato Franco. Metallothionein – Immunohistochemical Cancer Biomarker: A Meta-AnalysisPLoS ONE 2014; 9(1): e85346 doi: 10.1371/journal.pone.0085346
14
Yaru Guo, Mingna Xu, Yufei Lou, Yan Yuan, Yuling Wu, Longzhen Zhang, Yong Xin, Fengjuan Zhou, Mona Pathak. Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for esophageal squamous cell cancer: A meta-analysisPLOS ONE 2022; 17(8): e0271242 doi: 10.1371/journal.pone.0271242
15
Rene Kizek, Vojtech Adam, Jan Hrabeta, Tomas Eckschlager, Svatopluk Smutny, Jaroslav V. Burda, Eva Frei, Marie Stiborova. Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advancesPharmacology & Therapeutics 2012; 133(1): 26 doi: 10.1016/j.pharmthera.2011.07.006
16
Piotr Dziegiel, Bartosz Pula, Christopher Kobierzycki, Mariusz Stasiolek, Marzenna Podhorska-Okolow. Metallothioneins in Normal and Cancer CellsAdvances in Anatomy, Embryology and Cell Biology 2016; 218: 29 doi: 10.1007/978-3-319-27472-0_4
17
Ю.М. Гармаза, Е.И. Слобожанина. Modern Biomarkers for Assessing the Metabolic Status of Zinc in Humans and their Laboratory and Diagnostic Significance (Review)Лабораторная диагностика. Восточная Европа 2021; (1): 31 doi: 10.34883/PI.2021.10.1.004
18
Rolf König, Ping Cai, Xin Guo, G. A. S. Ansari. Transcriptomic Analysis Reveals Early Signs of Liver Toxicity in Female MRL +/+ Mice Exposed to the Acylating Chemicals Dichloroacetyl Chloride and Dichloroacetic AnhydrideChemical Research in Toxicology 2008; 21(3): 572 doi: 10.1021/tx7002728